Florida International University
Edit Your Profile
FIU Discovery
Toggle navigation
Browse
Home
People
Organizations
Scholarly & Creative Works
Research Facilities
Support
Edit Your Profile
CANCER
Journal
Overview
Research
Identifiers
Other
View All
Overview
publication venue for
NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma
. 126:2821-2828.
2020
Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations
. 125:2910-2914.
2019
Sleep disturbance, distress, and quality of life in ovarian cancer patients during the first year after diagnosis
. 119:3234-3241.
2013
The effect of copy number variation in the phase II detoxification genes UGT2B17 and UGT2B28 on colorectal cancer risk.
. 119:2477-2485.
2013
Fractionated radioimmunotherapy with
90
Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial
. 118:5497-5506.
2012
The influence of Hispanic ethnicity on nonsmall cell lung cancer histology and patient survival
. 118:4495-4501.
2012
A phase 1 trial of E7974 administered on day 1 of a 21-day cycle in patients with advanced solid tumors
. 118:4262-4270.
2012
Presentation, Patterns of Care, and Survival in Patients With Brain Metastases What Has Changed in the Last 20 Years?
. 117:2505-2512.
2011
Plasma Cell-Free DNA in Ovarian Cancer An Independent Prognostic Biomarker
. 116:1918-1925.
2010
Modeling excess lung cancer risk among screened arm participants in the mayo lung project
. 116:122-131.
2010
Survival Disparities Among African American Women With Invasive Bladder Cancer in Florida
. 115:4196-4209.
2009
A midpoint assessment of the American Cancer Society challenge goal to halve the US cancer mortality rates between the years 1990 and 2015
. 107:396-405.
2006
Cytokeratin 20 expression identifies a subtype of pancreatic adenocarcinoma with decreased overall survival
. 106:693-702.
2006
A phase I study of concurrent RMP-7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomas
. 104:1968-1974.
2005
Phase 1 study of concurrent RMP-7 and carboplatin with radiotherapy for children with newly diagnosed brainstern gliomas
. 104:1281-1287.
2005
Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma - A North American Brain Tumor Consortium Trial
. 100:1712-1716.
2004
Should decisions on internal mammary lymph node irradiation be based on current lymphoscintigraphy techniques for sentinel lymph node identification?
. 100:518-523.
2004
Histopathologic score predicts recurrence free survival after radical surgery in patients with stage IA(2)-IB1-2 cervical carcinoma
. 97:1904-1908.
2003
Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix - Clinical experience with and without concomitant chemotherapy
. 97:1781-1788.
2003
Does histology influence prognosis in patients with early-stage cervical carcinoma?
. 92:2999-3004.
2001
Evaluation of topotecan and etoposide for non-Hodgkin lymphoma - Correlation of topoisomerase-DNA complex formation with clinical response
. 91:463-471.
2001
A phase II study of paclitaxel in patients with recurrent malignant glioma using different doses depending upon the concomitant use of anticonvulsants -:
A North American Brain Tumor Consortium report
. 91:417-422.
2001
Antitumor activity of a novel glyco-nitric oxide conjugate in ovarian carcinoma
. 88:381-388.
2000
Is radical trachelectomy a safe alternative to radical hysterectomy for patients with stage IA-B carcinoma of the cervix?
. 86:2273-2279.
1999
Author reply
. 86:2187-2188.
1999
Infiltrating breast carcinoma smaller than 0.5 centimeters - Is lymph node dissection necessary?
. 85:2206-2211.
1999
The rectus abdominis myocutaneous flap - Modifications, complications, and sexual function
. 83:510-520.
1998
All-trans retinoic acid and interferon-alpha-2a in patients with metastatic or recurrent carcinoma of the uterine cervix - Clinical and pharmacokinetic studies
. 79:1574-1580.
1997
Circulating antibodies against p53 protein in patients with ovarian carcinoma - Correlation with clinicopathologic features and survival
. 78:2146-2152.
1996
Altered expression of transforming growth factor-beta 1 in cervical neoplasia as an early biomarker in carcinogenesis of the uterine cervix
. 77:1107-1114.
1996
PROMISING NEW THERAPIES IN THE TREATMENT OF ADVANCED OVARIAN-CANCER
. 76:2028-2033.
1995
HEREDITARY AND FAMILIAL OVARIAN-CANCER IN SOUTHERN ONTARIO
. 74:2341-2346.
1994
SINGLE-USE PERCUTANEOUS CATHETERS FOR INTRAPERITONEAL P-32 THERAPY
. 73:2633-2637.
1994
TAXOL IN OVARIAN-CANCER
. 71:1591-1596.
1993
ADENOCARCINOMA ARISING IN VULVAR BREAST-TISSUE
. 62:2234-2238.
1988
Response of tumor‐bearing rats to high‐fat total parenteral nutrition
. 56:2612-2616.
1985
MULTIENZYMATIC ANALYSES OF HUMAN-MALIGNANT LYMPHOMAS - CORRELATION OF ENZYMATIC DATA WITH PATHOLOGIC AND ULTRASTRUCTURAL FINDINGS IN BURKITTS AND LYMPHOBLASTIC LYMPHOMAS
. 54:489-499.
1984
SERIAL DETERMINATIONS OF ANTI-PLATELET ANTIBODIES IN A PATIENT WITH HODGKINS-DISEASE AND AUTOIMMUNE THROMBOCYTOPENIA
. 51:2057-2060.
1983
Innovations in understanding the biology of cervical cancer
2003
Lymphedema: Patient and provider education - Current status and future trends
1998
Workgroup II - Patient education - Pre- and posttreatment
1998
Infiltrating breast carcinoma smaller than 0.5 centimeters - Is lymph node dissection necessary?
1999
Infiltrating breast carcinoma smaller than 0.5 centimeters - Is lymph node dissection necessary? Reply
1999
A Systematic Review of the Cost and Cost-Effectiveness Studies of Proton Radiotherapy
2016
Identification of genetically predicted DNA methylation markers associated with non-small cell lung cancer risk among 34,964 cases and 448,579 controls.
2024
Detection of UGT1A10 polymorphisms and their association with orolaryngeal carcinoma risk.
2003
p53 alteration and human papilloma virus infection in paranasal sinus cancer.
1997
Research
category
ONCOLOGY
Category
Identifiers
International Standard Serial Number (ISSN)
0008-543X
Electronic International Standard Serial Number (EISSN)
1097-0142
Other
journal abbreviation
CANCER-AM CANCER SOC